Systematic Evolution of a DNA Aptamer Binding to Rat Brain Tumor Microvessels
暂无分享,去创建一个
H. Schluesener | M. Blank | T. Weinschenk | M Blank | T Weinschenk | M Priemer | H Schluesener | M. Priemer
[1] M. C. Alliegro. A C-terminal carbohydrate-binding domain in the endothelial cell regulatory protein, pigpen: new function for an EWS family member. , 2000, Experimental cell research.
[2] Vicki Brower,et al. Tumor angiogenesis—new drugs on the block , 1999, Nature Biotechnology.
[3] Dario Neri,et al. Selective targeting and photocoagulation of ocular angiogenesis mediated by a phage-derived human antibody fragment , 1999, Nature Biotechnology.
[4] S D Jayasena,et al. Staining of cell surface human CD4 with 2'-F-pyrimidine-containing RNA aptamers for flow cytometry. , 1998, Nucleic acids research.
[5] A. Pines,et al. High-resolution 27AI NMR spectroscopy of the aluminophosphate molecular sieve VPI-5 , 1990, Nature.
[6] A. Varki,et al. DNA aptamers block L-selectin function in vivo. Inhibition of human lymphocyte trafficking in SCID mice. , 1996, The Journal of clinical investigation.
[7] L. Zardi,et al. Increased binding affinity and valence of recombinant antibody fragments lead to improved targeting of tumoral angiogenesis. , 1999, Cancer research.
[8] A D Ellington,et al. In vitro selection of nucleic acid aptamers that bind proteins. , 1996, Methods in enzymology.
[9] K. Plate. Mechanisms of angiogenesis in the brain. , 1999, Journal of neuropathology and experimental neurology.
[10] S D Jayasena,et al. Use of a high affinity DNA ligand in flow cytometry. , 1996, Nucleic acids research.
[11] E. Ruoslahti,et al. Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. , 1998, Science.
[12] P. Thorpe,et al. Targeting the vasculature of solid tumors , 1993 .
[13] J. Folkman. Angiogenesis in cancer, vascular, rheumatoid and other disease , 1995, Nature Medicine.
[14] S. Jayasena. Aptamers: an emerging class of molecules that rival antibodies in diagnostics. , 1999, Clinical chemistry.
[15] Timo Sorsa,et al. Tumor targeting with a selective gelatinase inhibitor , 1999, Nature Biotechnology.
[16] M. Alliegro,et al. A nuclear protein regulated during the transition from active to quiescent phenotype in cultured endothelial cells. , 1996, Developmental biology.
[17] P. Kristjansen,et al. Tumor angiogenesis ‐ a new therapeutic target in gliomas , 1998, Acta neurologica Scandinavica.
[18] B. Zetter. On target with tumor blood vessel markers , 1997, Nature Biotechnology.
[19] D. N. Perkins,et al. Probability‐based protein identification by searching sequence databases using mass spectrometry data , 1999, Electrophoresis.
[20] J. Wills,et al. Isolation of virus-neutralizing RNAs from a large pool of random sequences. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[21] A. Shevchenko,et al. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. , 1996, Analytical chemistry.
[22] A. Crameri,et al. 10(20)-fold aptamer library amplification without gel purification. , 1993, Nucleic acids research.
[23] L. Gold,et al. High affinity ligands from in vitro selection: complex targets. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[24] Dario Neri,et al. Targeting by affinity–matured recombinant antibody fragments of an angiogenesis associated fibronectin isoform , 1997, Nature Biotechnology.
[25] F. Di Virgilio,et al. Mouse microglial cells express a plasma membrane pore gated by extracellular ATP. , 1996, Journal of immunology.
[26] T. Fitzwater,et al. A SELEX primer. , 1996, Methods in enzymology.
[27] Enrico A. Stura,et al. Functional Mimicry of a Protein Hormone by a Peptide Agonist: The EPO Receptor Complex at 2.8 Å , 1996, Science.
[28] W. Risau,et al. Mechanisms of angiogenesis , 1997, Nature.
[29] L. Lampson,et al. Disseminating tumor cells and their interactions with leukocytes visualized in the brain. , 1992, Cancer research.
[30] M. Gleichmann,et al. Both the Neuronal and Inducible Isoforms Contribute to Upregulation of Retinal Nitric Oxide Synthase Activity by Brain-Derived Neurotrophic Factor , 1999, The Journal of Neuroscience.
[31] L. Gold,et al. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. , 1990, Science.
[32] C. Koch,et al. Oxygen dependence of cellular uptake of EF5 [2-(2-nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl)a cet amide] : analysis of drug adducts by fluorescent antibodies vs bound radioactivity. , 1995, British Journal of Cancer.
[33] M Yarus,et al. Diversity of oligonucleotide functions. , 1995, Annual review of biochemistry.
[34] J. Sambrook,et al. Molecular Cloning: A Laboratory Manual , 2001 .